AGM/EGMApr 26, 2026, 05:31 AM
CGON Annual Meeting on June 4, 2026; Director Elections
AI Summary
CG Oncology, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 4, 2026. Stockholders will vote on the election of two Class II directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm, and advisory votes on executive compensation and the frequency of such votes. The record date for voting is April 7, 2026.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on June 4, 2026, at 10:00 a.m. Pacific Time.
- Stockholders of record as of April 7, 2026, are eligible to vote.
- Proposal 1: Elect two Class II directors, Christina Rossi and Victor Tong, Jr., to serve until the 2029 Annual Meeting.
- Proposal 2: Ratify Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026.
- Proposal 3: Advisory vote to approve the compensation of Named Executive Officers.
- Proposal 4: Advisory vote on the frequency of future executive compensation advisory votes (Board recommends "One Year").
Price Impact
More from CGON